Stocktaking and reconciliation of Pfizer-BioNTech COVID-19 Vaccine at PCN designated sites

Tracy Rogers, Interim Director, Medicines Use & Safety, Medicines Use and Safety TeamPublished

Standard Operating Procedure for stocktaking and reconciliation of Pfizer-BioNTech COVID-19 Vaccine at PCN designated sites

Information

A standard operating procedure is attached to this page.

You should also familiarise yourself with our background guide Facilitating pharmaceutical support to PCN designated sites before using this SOP.

 

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional in England, get in touch with us if you still have questions